» Articles » PMID: 22042863

Mst1 and Mst2 Protein Kinases Restrain Intestinal Stem Cell Proliferation and Colonic Tumorigenesis by Inhibition of Yes-associated Protein (Yap) Overabundance

Overview
Specialty Science
Date 2011 Nov 2
PMID 22042863
Citations 264
Authors
Affiliations
Soon will be listed here.
Abstract

Ablation of the kinases Mst1 and Mst2, orthologs of the Drosophila antiproliferative kinase Hippo, from mouse intestinal epithelium caused marked expansion of an undifferentiated stem cell compartment and loss of secretory cells throughout the small and large intestine. Although median survival of mice lacking intestinal Mst1/Mst2 is 13 wk, adenomas of the distal colon are common by this age. Diminished phosphorylation, enhanced abundance, and nuclear localization of the transcriptional coactivator Yes-associated protein 1 (Yap1) is evident in Mst1/Mst2-deficient intestinal epithelium, as is strong activation of β-catenin and Notch signaling. Although biallelic deletion of Yap1 from intestinal epithelium has little effect on intestinal development, inactivation of a single Yap1 allele reduces Yap1 polypeptide abundance to nearly wild-type levels and, despite the continued Yap hypophosphorylation and preferential nuclear localization, normalizes epithelial structure. Thus, supraphysiologic Yap polypeptide levels are necessary to drive intestinal stem cell proliferation. Yap is overexpressed in 68 of 71 human colon cancers and in at least 30 of 36 colon cancer-derived cell lines. In colon-derived cell lines where Yap is overabundant, its depletion strongly reduces β-catenin and Notch signaling and inhibits proliferation and survival. These findings demonstrate that Mst1 and Mst2 actively suppress Yap1 abundance and action in normal intestinal epithelium, an antiproliferative function that frequently is overcome in colon cancer through Yap1 polypeptide overabundance. The dispensability of Yap1 in normal intestinal homeostasis and its potent proliferative and prosurvival actions when overexpressed in colon cancer make it an attractive therapeutic target.

Citing Articles

AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer.

Zheng G, Yan Z, Zou J, Zou X, Chai K, Zhang G Front Oncol. 2025; 15:1520808.

PMID: 39963114 PMC: 11830605. DOI: 10.3389/fonc.2025.1520808.


Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics.

Ma X, Huang T, Chen X, Li Q, Liao M, Fu L Signal Transduct Target Ther. 2025; 10(1):63.

PMID: 39920130 PMC: 11806117. DOI: 10.1038/s41392-024-02104-8.


Activation of the conserved Hippo kinases by inflammasome-triggered proteolytic cleavage controls programmed cell death in macrophages.

Su Y, Quagliato S, St Louis B, Abdelaziz M, He Y, Bondage D Proc Natl Acad Sci U S A. 2025; 122(5):e2418613122.

PMID: 39883842 PMC: 11804562. DOI: 10.1073/pnas.2418613122.


Nicotine enhances the stemness and tumorigenicity in intestinal stem cells via Hippo-YAP/TAZ and Notch signal pathway.

Isotani R, Igarashi M, Miura M, Naruse K, Kuranami S, Katoh M Elife. 2025; 13.

PMID: 39752217 PMC: 11698494. DOI: 10.7554/eLife.95267.


Regulation of the Intestinal Stem Cell Pool and Proliferation in .

Trubin S, Patel D, Tian A Cells. 2024; 13(22).

PMID: 39594605 PMC: 11592481. DOI: 10.3390/cells13221856.


References
1.
van der Flier L, van Gijn M, Hatzis P, Kujala P, Haegebarth A, Stange D . Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell. 2009; 136(5):903-12. DOI: 10.1016/j.cell.2009.01.031. View

2.
Zhu L, Gibson P, Currle D, Tong Y, Richardson R, Bayazitov I . Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature. 2008; 457(7229):603-7. PMC: 2633030. DOI: 10.1038/nature07589. View

3.
Lu L, Li Y, Kim S, Bossuyt W, Liu P, Qiu Q . Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A. 2010; 107(4):1437-42. PMC: 2824398. DOI: 10.1073/pnas.0911427107. View

4.
Praskova M, Xia F, Avruch J . MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol. 2008; 18(5):311-21. PMC: 4682548. DOI: 10.1016/j.cub.2008.02.006. View

5.
Grivennikov S, Karin E, Terzic J, Mucida D, Yu G, Vallabhapurapu S . IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009; 15(2):103-13. PMC: 2667107. DOI: 10.1016/j.ccr.2009.01.001. View